SNSS
Sunesis Pharmaceuticals, Inc. Common Stock
stockNASDAQ
InactiveFeb 25, 2021
13.50USD+153.759%(+8.18)622,246
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
CEO
Dayton Misfeldt
HQ
South San Francisco, California, USA
Feb 25, 2021 · 2-for-7 (reverse)
SNSS Profile
Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.
SNSS Performance
| Period | Price | Date | Change |
|---|